Dan Nandan is the CEO of Staffingly, Inc. With 25+ years in IT consulting and a decade leading healthcare BPO operations across India, Latin America, and Pakistan, his team now serves 800+ U.S. healthcare providers across medical, dental, pharmacy, and post-acute care verticals.
2026 Compliance Verified: HIPAA, SOC 2 Type II, ISO 27001, HITRUST-aligned workflows.
Featured in Computerworld →State of Florida. Licensed Pharmacist (RPh)
Shammi Chapalamadugu, RPh is the Director of Pharmacy Operations at Staffingly, Inc. and a licensed pharmacist in the State of Florida (License No. PS39122). He reviews Staffingly’s pharmacy content for clinical accuracy and compliance, with hands-on experience across Part D submission, PBM coordination, prescription and refill workflows, MFP drug reconciliation, DIR fee tracking, and audit-ready documentation in long-term care, assisted living, and specialty pharmacy operations.
What Is Medicare part d billing LTC?
Medicare Part D covers outpatient prescription drugs for Medicare-enrolled individuals, including residents of long-term care facilities. In LTC settings, medications are dispensed by a contracted LTC pharmacy, not by retail pharmacies at a point of sale. CMS requires Part D plan sponsors to ensure LTC pharmacy access, which means plans must contract with LTC pharmacies and accommodate the unique dispensing and billing requirements of institutional settings.
Overview of Medicare Part D in Long-Term Care
Medicare Part D covers outpatient prescription drugs for Medicare-enrolled individuals, including residents of long-term care facilities. In LTC settings, medications are dispensed by a contracted LTC pharmacy, not by retail pharmacies at a point of sale. CMS requires Part D plan sponsors to ensure LTC pharmacy access, which means plans must contract with LTC pharmacies and accommodate the unique dispensing and billing requirements of institutional settings.
The fundamental difference between LTC and retail Part D billing is the post-consumption model. In retail pharmacy, the claim is adjudicated before the patient takes the medication. In LTC, the resident takes the medication first (often administered by nursing staff around the clock), and the claim is submitted afterward. Denials arrive after the clinical moment has passed, meaning the medication has already been consumed and cannot be “returned.” This creates financial exposure for both the pharmacy and the facility when claims are denied.
LTC residents are frequently dual-eligible, enrolled in both Medicare and Medicaid simultaneously. This makes formulary coordination a two-payer problem where the Part D formulary, the Medicaid formulary, and the LIS protections must all be considered for each prescription. Coordination of benefits errors between Medicare and Medicaid are among the most common billing failures in LTC settings.
What Makes LTC Different from Retail: The 14-day supply rule limits brand-name solid oral doses to 14-day dispensing increments. Unit dose packaging requires specific billing codes that differ from retail 30- or 90-day supplies. Retrospective Part A eligibility reviews can reverse claims months after submission. There is no true point of sale because medications are dispensed to a nursing unit, not to a patient at a counter. Every claim requires the NCPDP patient residence code (384-4X) and pharmacy service type (147-U7), and omitting either code causes automatic rejection with no exception process.
Why Part A vs. Part D Determination Is the First Billing Trap
When a Medicare beneficiary is admitted to a skilled nursing facility (SNF) following a qualifying 3+ day hospital stay, Medicare Part A covers their care for up to 100 days (60 days at full coverage, days 61-100 with a daily coinsurance). During Part A coverage, prescription drugs are bundled into the per diem payment that the SNF receives. Part D should not be billed during this period because the drugs are already covered under Part A.
The trap lies in the transition. When a resident’s Part A benefit period ends or the patient no longer meets the skilled care requirement, Part D billing must resume. But the transition date is not always obvious. A resident may lose Part A eligibility mid-week due to a clinical status change, and the pharmacy may not be notified for days. Pharmacies that miss this transition continue billing as if Part A is active (which generates no pharmacy claim because drugs are bundled), or they fail to initiate Part D claims promptly for the post-Part A period. CMS mandates retrospective review of Part A periods, reversal of any Part D claims that overlapped with Part A coverage, and refunds to beneficiaries who paid cost-sharing during a period when Part A should have covered the drugs.
This retrospective review can reach back months, creating a cascade of reversals, adjustments, and refund obligations that disrupts cash flow and creates compliance exposure for both the pharmacy and the facility.
State note: In Pennsylvania, residents enrolled in PACE (Program of All-Inclusive Care for the Elderly) programs are excluded from standard Part D entirely because PACE provides comprehensive drug coverage under its own benefit. Billing a PACE resident’s medications to Part D triggers overpayment recovery and compliance flags. Verify PACE enrollment at admission for every Pennsylvania resident.
Steps in Medicare Part D Billing for LTC Facilities
Step 1. Eligibility Verification at Admission. Confirm Medicare enrollment, the specific Part D plan (PDP or MAPD), dual eligibility, and LIS status. In IL, confirm which Medicaid MCO coordinates with Part D. In PA, confirm whether the resident is in PACE or Community HealthChoices.
Step 2. Formulary Mapping Before First Dispense. Cross-reference each prescription against the plan’s formulary. Flag drugs requiring PA, step therapy, or quantity limits. For Jardiance or Ozempic, confirm coverage tier and initiate PA before first dispense.
Step 3. Claims Submission with Required NCPDP Codes. Include patient residence code (384-4X) and pharmacy service type (147-U7). Missing codes trigger automatic rejection. For unit dose packaging, include the repackaging fee (up to $25.00 per claim at $0.02/unit).
Step 4. Monitor and Work Rejections. Track claim statuses actively. For rejected claims, identify root cause and reverse/resubmit within the timely filing window.
Step 5. Retrospective Part A Review. Monthly review of benefit periods. Reverse Part D claims overlapping Part A. Refund LIS beneficiaries any cost-sharing collected in error.
Save 40-70% with dedicated Coding specialists
Book a 15-minute call. We will map your current medical coding workflow, denial rates, and staff hours against what a dedicated team typically delivers in the first 30 days.
Compliance Requirements for Medicare Part D in LTC
LTC Part D billing operates under multiple overlapping compliance requirements. Missing any one creates audit exposure.
HIPAA and CMS Guidelines: All Part D transactions must comply with HIPAA electronic transaction standards. Claims data must be transmitted via encrypted channels between the pharmacy, clearinghouse, and Part D plan. CMS audit programs targeting LTC pharmacy billing include Zone Program Integrity Contractors (ZPIC) and Comprehensive Error Rate Testing (CERT) audits. ZPIC audits focus on billing patterns and may request documentation for specific claims. CERT audits randomly sample claims to calculate the overall error rate. Both can result in overpayment demand letters.
NCPDP Coding Compliance: The patient residence code (384-4X) must reflect the LTC setting on every pharmacy claim. The pharmacy service type (147-U7) must identify the LTC dispense type. These are not optional fields. Missing either code results in immediate claim rejection with no exception process and no workaround. Pharmacy billing systems must be configured to auto-populate these fields for all LTC patient claims. Manual entry is error-prone and should be eliminated.
Medicare Prescription Payment Plan (MPPP, 2025): The Inflation Reduction Act created a new installment payment option for Part D beneficiaries. LTC pharmacies must provide a “likely to benefit” notice to residents and track which residents have opted into MPPP installment payments. This affects how cost-sharing is collected and reported, adding a new administrative layer to LTC billing workflows.
LIS/Dual Eligible Protections: Full Low-Income Subsidy beneficiaries residing in nursing facilities pay $0 cost-sharing on covered Part D drugs in 2025 and 2026. This is a hard protection under CMS rules. Collecting any amount above the LIS limits from these residents triggers a repayment obligation and potential compliance action. Billing teams must verify LIS status at admission and monitor for changes.
Jardiance, Ozempic, and High-Cost Drugs in LTC: What Plans Actually Cover
Is Jardiance Covered by Medicare (Including PA)? Yes, most Part D plans cover Jardiance at Tier 3 or Tier 4 with PA. Documentation needed: T2D with inadequate glycemic control on first-line therapy plus prescriber confirmation. In Pennsylvania, confirm coverage with the specific plan for each resident.
2026 IRA Impact on Jardiance: Jardiance is among the first 10 drugs subject to CMS price negotiation. MFP takes effect January 1, 2026, lowering what plans pay but also reducing LTC pharmacy acquisition cost. Per-claim losses projected at $42.85-$54.09 (SCPC/ATI Advisory).
Does WellCare Part D Cover Ozempic? Yes, for Type 2 diabetes management with PA and step therapy. Not for weight loss alone. Documenting the cardiovascular benefit indication improves PA approval rates. GLP-1s for weight management remain excluded through 2026. CMS BALANCE Model begins July 2026.
How the IRA's Drug Price Negotiation Disrupts LTC Pharmacy Revenue in 2026
Starting January 1, 2026, CMS negotiated maximum fair prices take effect for 10 drugs including Jardiance, Eliquis, Xarelto, and Januvia. Many are high-frequency LTC prescriptions.
The MFP eliminates the traditional “spread” that LTC pharmacies recovered on branded drugs. The Senior Care Pharmacy Coalition lobbied for a $30 supply fee per prescription. As of April 2026, the bipartisan House bill is in committee.
What LTC billing teams should do: Audit top-volume Part D drugs against the 2026 negotiated list. Model revenue impact per-claim. Review contracts with plan sponsors. Document every dispense of negotiated drugs with full PA trails.
State-Level Complexity: What LTC Billers in GA, PA, and IL Face
Georgia: FFS model for most LTC pharmacy billing. Dual-eligible residents have Part D as primary payer for outpatient drugs. Confirm PDP vs. MAPD. SOURCE waiver drug coverage must not overlap with Part D.
Pennsylvania: PACE participants excluded from standard Part D. Community HealthChoices MCOs coordinate with Part D plans. WellCare’s PA requirements in PA follow national criteria but formularies change annually.
Illinois: Expanded Medicaid increased dual-eligible enrollment. Track which MCO coordinates with Part D for each resident. SLFs are not SNFs and may have different billing eligibility. Income limit for Medicaid LTC: $1,255/month for individuals (2025).
Benefits of Getting Medicare Part D Billing Right in LTC
Improved cash flow: Accurate eligibility verification prevents retroactive reversals that claw back revenue months after the claim was paid. Timely PA initiation reduces unbillable emergency supply gaps where the pharmacy absorbs the cost of medications dispensed before PA approval. Clean claim rates above 95% reduce rework costs, and every percentage point above 95% translates directly to fewer staff hours spent on denial resolution and resubmission.
Better resident care: Proactive billing means medications without interruption. Formulary alignment at admission prevents gaps in therapy that occur when a resident’s community medications are not on the LTC pharmacy’s Part D formulary. A medication gap during the first 72 hours of admission is both a clinical risk and a billing problem because emergency supply provisions must be invoked, creating documentation and PA obligations that would not exist if formulary alignment had been completed before admission.
Reduced audit exposure: Clean workflows reduce ZPIC (Zone Program Integrity Contractor) and CERT (Comprehensive Error Rate Testing) overpayment demand letters. LTC pharmacies that maintain accurate Part A/Part D overlap monitoring and proper NCPDP field coding are significantly less likely to receive audit findings than those that rely on manual processes and reactive correction.
Staffingly benchmarks: 99.2% clean claim rate. PA turnaround: 48-72 hours. 800+ providers. $399/week (volume discounts to $299/week). 70% cost reduction vs. in-house. SOC 2 Type II, HITRUST, ISO 27001, HIPAA compliant.
Overcoming Common Medicare Part D Billing Challenges
Common denial causes and their frequency (Change Healthcare Denials Index / CMS Part D data):
- Formulary non-coverage (~32%): The drug is not on the plan’s covered list.
- PA required but not obtained (~25%): The pharmacy dispensed before PA submission, or the claim was filed before PA approval.
- Incorrect eligibility (~18%): A missed Part A to Part D transition, a PACE enrollment not caught at admission, or LIS status not verified.
- Coding errors (~15%): Missing NCPDP patient residence code (384-4X) or pharmacy service type (147-U7), which causes automatic rejection.
- Late submission (~10%): The claim was held pending PA approval and the timely filing window closed.
PA in LTC is Different from Retail: CMS allows LTC pharmacies to dispense up to a 31-day emergency supply for non-formulary or PA-required drugs when the prescriber attests to medical need. This is a critical protection for residents who need medications immediately and cannot wait for PA approval. However, the emergency supply creates a billing obligation: the pharmacy must document every emergency dispense, submit the PA immediately upon dispensing, track the PA decision, and submit the claim as soon as the PA is approved. If the PA is denied, the pharmacy must work the appeal within the payer’s timeline. Emergency supply claims that are submitted without the PA approval number will be denied, and the pharmacy bears the cost of the medication already dispensed.
Technology requirements for LTC billing accuracy: Real-time eligibility tools must be configured to check both Part A status and Part D plan enrollment simultaneously to prevent overlap billing. Automated PA tracking must alert the billing team when a PA-required medication is dispensed under emergency supply before the PA is approved. NCPDP field validation must be built into the pharmacy billing system so that patient residence codes and pharmacy service types auto-populate for every LTC claim, eliminating the manual entry errors that cause automatic rejections. Part A/Part D overlap monitoring should run on a monthly schedule, cross-referencing benefit periods against submitted Part D claims to identify and reverse any overlapping claims before a CMS audit finds them.
How Staffingly Supports LTC Billing Teams
Staffingly provides dedicated LTC billing support staffed by U.S.-trained specialists, PharmDs, and RNs with LTC pharmacy experience. Services include Part D eligibility verification, PA management for high-cost drugs, claims submission, denial management, Part A/Part D overlap audits, and NCPDP compliance review.
All work is HIPAA, SOC 2 Type II, HITRUST, and ISO 27001 compliant. 48-72 hour PA turnaround. 99.2% clean claim rate. $399/week (volume discounts to $299/week) with 70% cost reduction vs. in-house.
Staffingly operates across GA, PA, IL and all 50 states, covering state-specific Medicaid coordination, PACE exclusions, CHC workflows, and MCO-Part D coordination.
FAQ Section (7 Questions)
FAQ 1: What is Medicare Part D and how does it apply to LTC facilities? Medicare Part D covers prescription drugs for Medicare enrollees. In LTC, drugs are dispensed by contracted LTC pharmacies before claims are fully adjudicated, creating a post-consumption billing model with unique compliance obligations.
FAQ 2: Are all LTC facility residents eligible for Medicare Part D? Not automatically. Residents must be enrolled in Medicare and actively enrolled in a Part D plan. Pennsylvania PACE residents are excluded from standard Part D. Dual-eligible residents are auto-enrolled in benchmark plans with LIS protections.
FAQ 3: Does Medicare Part D cover Jardiance in a nursing home? Yes, most plans cover Jardiance with PA at Tier 3 or 4. Prescriber must document T2D medical necessity and prior first-line therapy. Starting 2026, Jardiance is subject to IRA price negotiation, affecting LTC pharmacy margins.
FAQ 4: Does WellCare Part D cover Ozempic for nursing home residents? WellCare covers Ozempic for T2D with PA and step therapy. Not for weight loss. Documenting cardiovascular benefit strengthens the PA. GLP-1s for weight management are excluded from Part D through 2026.
FAQ 5: How are claims submitted for Medicare Part D in LTC? Electronically, with required NCPDP fields: patient residence code (384-4X) and pharmacy service type (147-U7). Missing codes cause automatic rejection. Unit dose repackaging fees apply up to $25.00 per claim.
FAQ 6: What happens when a Part D claim is denied in LTC? The pharmacy can appeal, work with the physician on documentation, request formulary exceptions, correct coding errors, or reverse Part A overlap claims. While the appeal is pending, CMS lets LTC pharmacies dispense up to a 31-day emergency supply for non-formulary or PA-required drugs when the prescriber attests to medical need.
FAQ 7: How does the IRA’s drug price negotiation impact LTC pharmacy billing in 2026? CMS negotiated prices for 10 drugs take effect January 1, 2026. LTC pharmacies face projected per-prescription losses of $42.85-$54.09 on these drugs unless a legislated supply fee is enacted. Billing teams should audit affected drug volumes and model revenue impact.
Ready to Cut Prior Authorization and Eligibility Headaches?
Staffingly helps practices like yours get paid faster with a 99.2% clean-claim rate, 65-70% cost savings, and 48-72 hour go-live. SOC 2 Type II, HITRUST, and ISO 27001 certified. HIPAA compliant. MGMA Corporate Member.
- Start a 15-Day Risk-Free Pilot and see results before you commit.
- Call us: (800) 489-5877
Frequently Asked Questions
Related Services
Teams handling LTC Part D billing often pair it with these workflows: LTC pharmacy census and payer change automation keeps Part A/Part D and plan changes current across the census; SNF and long-term care eligibility verification confirms plan, dual, and LIS status at admission; and denial management and appeal drafting works rejected and PA-related claims before the timely filing window closes.
